当前位置:首页 > 期刊 > 《健康大视野·医学分册》 > 2018年第20期 > 正文
编号:13335456
心血管内科非瓣膜性心房颤动住院患者抗凝治疗现状分析(1)
http://www.100md.com 2018年10月15日 《健康大视野》2018年第20期
     【摘 要】目的:探析心血管内科非瓣膜性心房颤动住院患者抗凝治疗现状。方法:收集2015年3月——2017年12月于笔者所在医院心血管内科就诊的200例非瓣膜性房颤患者临床资料,回顾性分析本组病例基本特征、临床治疗方案等情况。结果:①本组接受单药抗凝治疗者46例(22.00%),单用抗血小板治疗者112例(56.00%),联合抗栓治疗者4例(2.00%),未接受抗凝治疗者38例(19.00%);②非瓣膜性心房颤动患者抗凝治疗与高龄、合并冠心病、存在脑卒中史、存在出血史等因素有关。结论:临床治疗非瓣膜性心房颤动患者中主要以抗凝为主,但现阶段临床抗凝治疗率较低,新型口服抗凝药物尚未广泛普及。

    【关键词】心血管内科;非瓣膜性心房颤动;抗凝治疗

    Abstract:Objective To explore the current situation of anticoagulation therapy in hospitalized patients with non valvular atrial fibrillation in cardiovascular department. Methods: the clinical data of 200 patients with non valvular atrial fibrillation (non valvular atrial fibrillation) in the Department of cardiovascular medicine from March 2015 to December 2017 were collected. The basic features of the cases and the clinical treatment plan were analyzed retrospectively. Results: (1) 46 cases (22%) were treated with single drug anticoagulant therapy ......
1 2下一页

您现在查看是摘要页,全文长 3423 字符